Loncar Cancer Immunotherapy ETF’s (CNCR) Moving Averages Convergence Divergence (MACD) indicator is -0.36, suggesting Loncar Cancer Immunotherapy ETF is a Buy.
Loncar Cancer Immunotherapy ETF’s (CNCR) 20-Day exponential moving average is 14.52, making it a Sell.
Loncar Cancer Immunotherapy ETF’s (CNCR) 50-Day exponential moving average is 14.76, making it a Sell.